Jeong Hyoseon, Hyun Junghee, Lee Yeon-Kyeng
Division of Healthcare Associated Infection Control, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Osong Public Health Res Perspect. 2023 Aug;14(4):312-320. doi: 10.24171/j.phrp.2023.0069. Epub 2023 Aug 21.
We aimed to describe the epidemiological characteristics of carbapenemase-producing Enterobacteriaceae (CPE) outbreaks in healthcare settings in the Republic of Korea between 2017 and 2022.
Under the national notifiable disease surveillance system, we obtained annual descriptive statistics regarding the isolated species, carbapenemase genotype, healthcare facility type, outbreak location and duration, and number of patients affected and recommended interventions. We used epidemiological investigation reports on CPE outbreaks reported to Korea Disease Control and Prevention Agency from June 2017 to September 2022.
Among the 168 reports analyzed, Klebsiella pneumoniae (85.1%) was the most frequently reported species, while K. pneumoniae carbapenemase (KPC, 82.7%) was the most common carbapenemase genotype. Both categories increased from 2017 to 2022 (p<0.01). General hospitals had the highest proportion (54.8%), while tertiary general hospitals demonstrated a decreasing trend (p<0.01). The largest proportion of outbreaks occurred exclusively in intensive care units (ICUs, 44.0%), and the frequency of concurrent outbreaks in ICUs and general wards increased over time (p<0.01). The median outbreak duration rose from 43.5 days before the coronavirus disease 2019 (COVID-19) pandemic (2017-2019) to 79.5 days during the pandemic (2020-2022) (p=0.01), and the median number of patients associated with each outbreak increased from 5.0 to 6.0 (p=0.03). Frequently recommended interventions included employee education (38.1%), and 3 or more measures were proposed for 45.2% of outbreaks.
In the Republic of Korea, CPE outbreaks have been consistently dominated by K. pneumoniae and KPC. The size of these outbreaks increased during the COVID-19 pandemic. Our findings highlight the need for continuing efforts to control CPE outbreaks using a multimodal approach, while considering their epidemiology.
我们旨在描述2017年至2022年韩国医疗机构中产碳青霉烯酶肠杆菌科细菌(CPE)暴发的流行病学特征。
在国家法定传染病监测系统下,我们获取了关于分离菌种、碳青霉烯酶基因型、医疗机构类型、暴发地点和持续时间以及受影响患者数量和推荐干预措施的年度描述性统计数据。我们使用了2017年6月至2022年9月期间向韩国疾病控制与预防机构报告的CPE暴发的流行病学调查报告。
在分析的168份报告中,肺炎克雷伯菌(85.1%)是报告最频繁的菌种,而肺炎克雷伯菌碳青霉烯酶(KPC,82.7%)是最常见的碳青霉烯酶基因型。这两类在2017年至2022年期间均有所增加(p<0.01)。综合医院的比例最高(54.8%),而三级综合医院呈下降趋势(p<0.01)。最大比例的暴发仅发生在重症监护病房(ICU,44.0%),并且ICU和普通病房同时暴发的频率随时间增加(p<0.01)。暴发的中位持续时间从2019冠状病毒病(COVID-19)大流行前(2017 - 2019年)的43.5天增加到流行期间(2020 - 2022年)的79.5天(p = 0.01),每次暴发相关患者的中位数量从5.0增加到6.0(p = 0.03)。经常推荐的干预措施包括员工教育(38.1%),45.2%的暴发提出了3项或更多措施。
在韩国,CPE暴发一直以肺炎克雷伯菌和KPC为主。在COVID-19大流行期间,这些暴发的规模有所增加。我们的研究结果强调,在考虑CPE流行病学的同时,需要继续努力采用多模式方法控制CPE暴发。